Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Medtronic plc
  6. News
  7. Summary
    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medtronic Receives FDA Approval For Spinal Cord Stimulation for Chronic Pain Due to Diabetic Peripheral Neuropathy

01/24/2022 | 12:35pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about MEDTRONIC PLC
05/23Cowen Lowers Medtronic's Price Target to $125 From $141, Maintains Outperform Rating
MT
05/19Medtronic to announce financial results for its fourth quarter and full fiscal year 202..
PR
05/19Oppenheimer Adjusts Medtronic Price Target to $120 From $125, Maintains Outperform Rati..
MT
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Medtronic's Price Target to $120 From $127, Reiterates Buy Rating
MT
05/17EUROPCR : Medtronic renal denervation system shows better blood pressure control with sign..
AQ
05/13Medtronic Says FDA Approves Onyx Frontier Drug-Eluting Stent
DJ
05/13Medtronic Receives US FDA Ok for Onyx Frontier Drug-Eluting Coronary Stent System
MT
05/13Medtronic receives FDA approval for latest generation drug-eluting coronary stent syste..
PR
05/13Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent Syste..
CI
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 051 M - -
Net income 2022 5 743 M - -
Net Debt 2022 20 802 M - -
P/E ratio 2022 26,5x
Yield 2022 2,29%
Capitalization 142 B 142 B -
EV / Sales 2022 5,07x
EV / Sales 2023 4,84x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 105,59 $
Average target price 122,23 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Megan Fulton Riddle Vice President
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Scientific, Medical & Regulatory Officer
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC0.78%139 869
ABBOTT LABORATORIES-18.27%201 411
BECTON, DICKINSON AND COMPANY4.57%73 262
HOYA CORPORATION-21.65%38 307
BAXTER INTERNATIONAL INC.-14.53%36 944
AMERISOURCEBERGEN CORPORATION13.01%31 985